XBiotech Inc.
XBIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $173 | $200 | $157 | $237 |
| Short-Term Investments | $0 | $0 | $60 | $0 |
| Receivables | $1 | $1 | $2 | $9 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $175 | $202 | $220 | $247 |
| Property Plant & Equip (Net) | $25 | $25 | $26 | $28 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $2 | $1 |
| Other NC Assets | $0 | $0 | -$2 | -$1 |
| Total NC Assets | $25 | $25 | $26 | $28 |
| Other Assets | $0 | $0 | $0 | -$0 |
| Total Assets | $199 | $227 | $246 | $275 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $2 |
| Short-Term Debt | $10 | $0 | $0 | $0 |
| Tax Payable | $2 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $4 | $2 | $1 |
| Total Curr. Liab. | $15 | $6 | $4 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $2 | $2 | $2 | $1 |
| Total NC Liab. | $2 | $2 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $17 | $8 | $6 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $273 | $271 | $267 | $262 |
| Retained Earnings | -$91 | -$52 | -$28 | $5 |
| AOCI | $0 | $0 | $1 | $2 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $182 | $219 | $240 | $269 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $199 | $227 | $246 | $275 |
| Net Debt | -$162 | -$200 | -$157 | -$237 |